Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pennant GroupPNTG -0.93%88 EV-to-EBIT is 34.08 as of Jul. 29, 2026, which is 28% below its 10-year median of 47.17. GuruFocus rates PNTG with a GF Score™ of 88/100 and a GF Value™ of $34.99 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Pennant Group ranks worse than 79.83% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Pennant Group's Enterprise Value for the quarter that ended in Mar. 2026 was $1,550 Mil.
Pennant Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pennant Group EV-to-EBIT Related Terms
Pennant Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Pennant Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Pennant Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Pennant Group's EV-to-EBIT falls into.
Pennant Group's current Enterprise Value is $1,939 Mil.
Pennant Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pennant Group (PNTG) has a EV-to-EBIT of 34.08 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Pennant Group and its competitors. This is 28% below median its historical median of 47.17. According to the industry distribution chart, Pennant Group ranks #376 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 79.8%.
Is Pennant Group's EV-to-EBIT too high?
Pennant Group's current EV-to-EBIT of 34.08 is 28% below median its 10-year median of 47.17. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Pennant Group's value of 34.08 is 116.5% above this industry median. Based on the distribution chart, Pennant Group ranks #376 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pennant Group has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's EV-to-EBIT compare to ARDT and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #376 out of 471 companies for EV-to-EBIT. This places Pennant Group in the lower half of its industry. The industry median EV-to-EBIT is 15.74. Pennant Group's value of 34.08 is 116.5% above this benchmark. While the company's 10-year median is 47.17 vs. the industry median of 15.74, Pennant Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pennant Group's current EV-to-EBIT of 34.08 is 116.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Pennant Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current EV-to-EBIT is 34.08, which is 28% below median its own 10-year median of 47.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $34.99, compared to a current price of $41.63 — trading 19% above its estimated fair value. The current EV-to-EBIT is 34.08, which is 28% below median its 10-year median of 47.17 and 116.5% above the Healthcare Providers & Services industry median of 15.74. Pennant Group's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Pennant Group (PNTG), the current EV-to-EBIT is 34.08 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $41.63 is trading 19% above its estimated GF Value™ of $34.99.
GuruFocus considers Pennant Group to be Modestly Overvalued.
Key valuation signals for PNTG:
EV-to-EBIT: 34.08 (28% below median its 10-year median of 47.17)
GF Value™: $34.99 vs. price of $41.63 (19% above fair value)
Industry Position: 116.5% above the Healthcare Providers & Services median (#376 of 471)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
88GF Score
Get the complete analysis for PNTG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
